Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New compound and preparation method and application thereof

A compound and application technology, applied in the field of chemical synthesis, can solve problems such as complicated operation, and achieve the effect of less by-products and easy operation

Inactive Publication Date: 2010-11-24
SHANGHAI TECHWELL BIOPHARMACEUTICALS CO LTD
View PDF5 Cites 33 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the reaction, a variety of uncommon reagents are used, and the operation is relatively complicated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New compound and preparation method and application thereof
  • New compound and preparation method and application thereof
  • New compound and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0088] The prostacyclin UT15 obtained by the preparation method provided by the present invention can be used to prepare a drug for treating pulmonary hypertension, and the drug contains an effective amount of the prostacyclin UT15 and a pharmaceutically acceptable carrier.

[0089] As used herein, the terms "comprising" or "comprising" include "comprising", "consisting essentially of", and "consisting of".

[0090] As used herein, the term "consisting essentially of" means that in addition to essential ingredients or essential components, the composition may also contain a small amount of secondary ingredients and / or impurities that do not affect the active ingredients. For example, sweeteners to improve taste, antioxidants to prevent oxidation, and other additives commonly used in the art may be contained.

[0091] As used herein, the term "effective amount" refers to an amount that can produce functions or activities on humans and / or animals and that can be accepted by huma...

Embodiment 1

[0105] Preparation of compound I

[0106] Compound II (2.80 g) was dissolved in 14 ml of tetrahydrofuran, then 21 ml of water and 42 ml of glacial acetic acid were added, and stirred to dissolve. N 2 Under protection, heated to 45°C and stirred for 4h. Slowly cool to room temperature, add semi-saturated brine (120ml), ethyl acetate (120ml) and stir to separate the layers, back-extract the aqueous layer with ethyl acetate (60ml), combine the ethyl acetate layers, and saturated sodium ), washed with saturated sodium chloride (100ml), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain compound 4 as a colorless oil, which was purified by silica gel column chromatography to obtain compound I (1.4g). m / z: 353.3(M+Na+)1H NMR (MeOD, 500MHz) δ0.89(t, 3H), 1.1-2.30(m, 17H), 2.41-2.45(m, 2H), 2.64-2.78(m, 2H), 3.45-3.54(m, 1H), 3.55-3.81(m, 1H), 5.67(m, 1H), 5.69(m, 1H), 6.65(d, 1H), 6.73(d, 1H), 6.99 (t, 1H); 13C NMRδ14.4, 23.8, 26.9, 29.9, 33.5, ...

Embodiment 2

[0108] Preparation of compound III

[0109] The compound I obtained in Example 1 was dissolved in ethyl acetate (56ml) in a 1L hydrogenation shaker flask, 10% palladium carbon (0.18g) was added, and the mixture was shaken at 20-25°C and hydrogen pressure of 50-60Psi for 8h. After adding a small amount of diatomaceous earth for filtration, the filtrate was concentrated to dryness under reduced pressure to obtain compound III (1.2 g). mp113-115°C; [a] 25 D +50.8 (c 0.324, MeOH).IR 3415, 3060, 2932, 753, and 702cm-1; m / z: 355.3 (M+Na + ); 1H NMR (MeOD, 500MHz) δ0.89(t, 3H), 1.1-2.30(m, 15H), 2.41-2.45(m, 2H), 2.64-2.78(m, 2H), 3.45-3.54(m, 1H ), 3.55-3.81(m, 1H), 5.66-5.70(m, 2H), 6.65(d, 1H), 6.73(d, 1H), 6.99(t, 1H);

[0110] 13 C NMR (MeOH, 125MHz) δ14.7, 24.0, 26.8, 26.9, 29.9, 33.5, 34.5, 34.9, 36.4, 38.6, 42.3, 42.7, 52.9, 73.2, 77.9, 114.1, 120.8, 126.4, 127.3, 142.2, 155.5 .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new compound and a preparation method and application thereof. The new compound is shown as a formula I.

Description

technical field [0001] The present invention relates to the field of chemical synthesis, in particular to a new compound and its intermediate in prostacyclin UT15, i.e. (1R, 2R, 3aS, 9aS)-2,3,3a,4,9,9a-hexahydro - Application in the synthesis of 1-[(3S)-3-hydroxyoctyl]-1H-benzo[f]indene-2,5-diol. Background technique [0002] Prostacyclin UT15 (Treprostinil) is a new class of drugs for the treatment of pulmonary arterial hypertension. Its structure is shown in formula IV: [0003] [0004] Pulmonary arterial hypertension (PAH) is a disease characterized by vasospasm, intimal hyperplasia and remodeling of pulmonary arterioles. Vascular proliferation and remodeling of pulmonary arterioles lead to a progressive increase in pulmonary vascular resistance, eventually leading to right ventricular failure and death. [0005] Epoprostenol (Flolan) is the first prostacyclin drug approved by the US Food and Drug Administration (FDA) for the treatment of PAH. The half-life of epo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C39/23C07C37/00C07C39/00C07C59/72C07C51/08A61K31/192A61P9/12
CPCY02P20/55
Inventor 唐志军何兵明李林卓忠浩郑云满高霄梁季晓铭
Owner SHANGHAI TECHWELL BIOPHARMACEUTICALS CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com